Cognitive effects of a Ginkgo biloba/vinpocetine compound in normal adults: systematic assessment of perception, attention and memory

被引:36
作者
Polich, J [1 ]
Gloria, R [1 ]
机构
[1] Scripps Res Inst, Cognit Electrophysiol Lab, Dept Neuropharmacol TPC10, La Jolla, CA 92037 USA
关键词
Ginkgo biloba; cognitive assessment; perception; attention; short-term memory;
D O I
10.1002/hup.308
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
A computerized test battery was used in a double-blind design to assess the cognitive effects of a nutrient compound containing Ginkgo biloba in 24 normal adults. Ten tasks (perceptual, attention and short-term memory) were presented in a standardized manner designed to maximize performance, with substantial pre-test practice employed to minimize response variability. Subjects were given either placebo or Ginkgo biloba extract capsules to consume for 14 days, after which they performed all tasks twice. They then received the other condition, and after 14 days completed the final test session. Response time and error rate stabilized after pre-test practice. A 'working memory capacity' paradigm demonstrated a reliable 50 ms response time decrease between the placebo and Ginkgo biloba testing, suggesting that Ginkgo biloba speeds short-term working memory processing in normal adults. Copyright (C) 2001 John Wiley & Sons, Ltd.
引用
收藏
页码:409 / 416
页数:8
相关论文
共 32 条
[1]  
ALLAIN H, 1993, CLIN THER, V15, P549
[2]  
[Anonymous], 1994, INDIVIDUAL DIFFERENC
[3]   A DOUBLE-BLIND PLACEBO CONTROLLED EVALUATION OF THE SAFETY AND EFFICACY OF VINPOCETINE IN THE TREATMENT OF PATIENTS WITH CHRONIC VASCULAR SENILE CEREBRAL-DYSFUNCTION [J].
BALESTRERI, R ;
FONTANA, L ;
ASTENGO, F .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1987, 35 (05) :425-430
[4]   Therapeutic value of Ginkgo biloba in reducing symptoms of decline in mental function [J].
Curtis-Prior, P ;
Vere, D ;
Fray, P .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1999, 51 (05) :535-541
[5]  
Eckmann F, 1990, Fortschr Med, V108, P557
[6]  
GESSNER B, 1985, ARZNEIMITTEL-FORSCH, V35-2, P1459
[7]  
Grassel E, 1992, Fortschr Med, V110, P73
[8]  
HINDMARCH I, 1986, PRESSE MED, V15, P1592
[9]  
HOFFERBERTH B, 1989, ARZNEIMITTEL-FORSCH, V39-2, P918
[10]  
Itil TM, 1998, PSYCHOPHARMACOL BULL, V34, P391